Aline S C Fabricio

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

The International journal of biological markers

Clinical chemistry and laboratory medicine

Journal of evaluation in clinical practice

Journal of personalized medicine

Azienda ULSS 3 Serenissima

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda ULSS 3 Serenissima May 15 2007

Italy

Scientific Coordinator / Senior Researcher :: Regional Center for Biomarkers

Centro di Riferimento Oncologico

Italy

Senior Researcher :: Struttura Operativa Complessa di Farmacologia Sperimentale e Clinica

Regional Center for Biomarkers - Azienda ULSS12 Veneziana

Italy

Scientific Coordinator :: Regional Center for Biomarkers

Publications

Elia Cappelletto, Laura Tiozzo Fasiolo, Valentina Salizzato, Luisa Piccin, Alessio Fabozzi, Anna Contato, Paola Del Bianco, Giulia Pasello, Vanna Chiarion-Sileni, Massimo Gion, Aline S C Fabricio
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations. The International journal of biological markers 39 (1) (2024)
Massimo Gion, Roberto De Gobbi, Manuel Zorzi, Giovanni Carretta, Luca Leonardi, Stefano Guzzinati, Chiara Trevisiol, Maurizio Cancian, Giulia Cardinali, Federica Michieletto, Ruggero Dittadi, Aline S C Fabricio, Massimo Rugge, Francesca Russo
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records. The International journal of biological markers (2023)
Massimo Gion, Roberto De Gobbi, Manuel Zorzi, Giovanni Carretta, Luca Leonardi, Stefano Guzzinati, Chiara Trevisiol, Maurizio Cancian, Giulia Cardinali, Federica Michieletto, Ruggero Dittadi, Aline S C Fabricio, Massimo Rugge, Francesca Russo
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records. The International journal of biological markers (2023)
Massimo Gion, Giulia Cardinali, Stefano Guzzinati, Paolo Morandi, Chiara Trevisiol, Aline S C Fabricio, Massimo Rugge, Manuel Zorzi
Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients. Risk management and healthcare policy 15 (2022)
Ruggero Dittadi, Aline S C Fabricio, Massimo Gion
Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful? Clinical chemistry and laboratory medicine 60 (6) (2022)
Maryam Zare Jeddi, Teresa Dalla Zuanna, Giulia Barbieri, Aline S C Fabricio, Francesca Daprà, Tony Fletcher, Francesca Russo, Gisella Pitter, Cristina Canova
Associations of Perfluoroalkyl Substances with Prevalence of Metabolic Syndrome in Highly Exposed Young Adult Community Residents-A Cross-Sectional Study in Veneto Region, Italy. International journal of environmental research and public health 18 (3) (2021)
Sara Ferro, Daniele Bottigliengo, Dario Gregori, Aline S C Fabricio, Massimo Gion, Ileana Baldi
Phenomapping of Patients with Primary Breast Cancer Using Machine Learning-Based Unsupervised Cluster Analysis. Journal of personalized medicine 11 (4) (2021)
Maryam Zare Jeddi, Rozita Soltanmohammadi, Giulia Barbieri, Aline S C Fabricio, Gisella Pitter, Teresa Dalla Zuanna, Cristina Canova
To which extent are per-and poly-fluorinated substances associated to metabolic syndrome? Reviews on environmental health (2021)
Jamal Elhasnaoui, Valentina Miano, Giulio Ferrero, Elena Doria, Antonette E Leon, Aline S C Fabricio, Laura Annaratone, Isabella Castellano, Anna Sapino, Michele De Bortoli
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3'-End Usage. Cancers 12 (6) (2020)
Valentina Agnolon, Anna Contato, Anna Meneghello, Elda Tagliabue, Giuseppe Toffoli, Massimo Gion, Federico Polo, Aline S C Fabricio
ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab. Scientific reports 10 (1) (2020)
Aline S C Fabricio, Silvia Michilin, Matelda Zancan, Valentina Agnolon, Lucia Peloso, Ruggero Dittadi, Antonio Scapinello, Claudio Ceccarelli, Massimo Gion
Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels. Scandinavian journal of clinical and laboratory investigation 79 (4) (2019)
Ruggero Dittadi, Aline S C Fabricio, Giulia Rainato, Edoardo Peroni, Fulvio Di Tonno, Beatrice Vezzù, Chiara Mazzariol, Elisa Squarcina, Laura Tammone, Massimo Gion
Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination. Clinical chemistry and laboratory medicine 57 (4) (2019)
Massimo Gion, Giulia Cardinali, Chiara Trevisiol, Marco Zappa, Giulia Rainato, Aline S C Fabricio
Indicators of inappropriate tumour marker use through the mining of electronic health records. Journal of evaluation in clinical practice 23 (4) (2017)

Aline S C Fabricio.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aline S C Fabricio